"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","treatment_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_phone","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","contact_web_link","supplementary_file","data_row_count","relation","relation.1"
"GSM452552","patient 100, cancer, LCM","GSM452552","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452552/GSM452552.CEL.gz","54675","Reanalyzed by: GSM537331","Reanalyzed by: GSM687469"
"GSM452553","patient 101, cancer, LCM","GSM452553","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452553/GSM452553.CEL.gz","54675","Reanalyzed by: GSM537332","Reanalyzed by: GSM687470"
"GSM452554","patient 102, cancer, LCM","GSM452554","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452554/GSM452554.CEL.gz","54675","Reanalyzed by: GSM537333","Reanalyzed by: GSM687471"
"GSM452555","patient 103, cancer, LCM","GSM452555","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452555/GSM452555.CEL.gz","54675","Reanalyzed by: GSM537334","Reanalyzed by: GSM687472"
"GSM452556","patient 104, cancer, LCM","GSM452556","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452556/GSM452556.CEL.gz","54675","Reanalyzed by: GSM537335","Reanalyzed by: GSM687473"
"GSM452557","patient 107, cancer, LCM","GSM452557","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452557/GSM452557.CEL.gz","54675","Reanalyzed by: GSM537336","Reanalyzed by: GSM687475"
"GSM452558","patient 111, cancer, LCM","GSM452558","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452558/GSM452558.CEL.gz","54675","Reanalyzed by: GSM537339","Reanalyzed by: GSM687479"
"GSM452559","patient 113, cancer, LCM","GSM452559","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452559/GSM452559.CEL.gz","54675","Reanalyzed by: GSM537340","Reanalyzed by: GSM687480"
"GSM452560","patient 115, cancer, LCM","GSM452560","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452560/GSM452560.CEL.gz","54675","Reanalyzed by: GSM537341","Reanalyzed by: GSM687481"
"GSM452561","patient 116, cancer, LCM","GSM452561","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452561/GSM452561.CEL.gz","54675","Reanalyzed by: GSM537342","Reanalyzed by: GSM687482"
"GSM452562","patient 117, cancer, LCM","GSM452562","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452562/GSM452562.CEL.gz","54675","Reanalyzed by: GSM537343","Reanalyzed by: GSM687483"
"GSM452563","patient 118, cancer, LCM","GSM452563","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452563/GSM452563.CEL.gz","54675","Reanalyzed by: GSM537344","Reanalyzed by: GSM687484"
"GSM452564","patient 119, cancer, LCM","GSM452564","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452564/GSM452564.CEL.gz","54675","Reanalyzed by: GSM537345","Reanalyzed by: GSM687485"
"GSM452565","patient 011, cancer, LCM","GSM452565","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452565/GSM452565.CEL.gz","54675","Reanalyzed by: GSM537346",""
"GSM452566","patient 123, cancer, LCM","GSM452566","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452566/GSM452566.CEL.gz","54675","Reanalyzed by: GSM537347","Reanalyzed by: GSM687488"
"GSM452567","patient 124, cancer, LCM","GSM452567","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452567/GSM452567.CEL.gz","54675","Reanalyzed by: GSM537348","Reanalyzed by: GSM687489"
"GSM452568","patient 125, cancer, LCM","GSM452568","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452568/GSM452568.CEL.gz","54675","Reanalyzed by: GSM537349","Reanalyzed by: GSM687490"
"GSM452569","patient 127, cancer, LCM","GSM452569","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452569/GSM452569.CEL.gz","54675","Reanalyzed by: GSM537350","Reanalyzed by: GSM687491"
"GSM452570","patient 128, cancer, LCM","GSM452570","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452570/GSM452570.CEL.gz","54675","Reanalyzed by: GSM537351","Reanalyzed by: GSM687492"
"GSM452571","patient 134, cancer, LCM","GSM452571","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452571/GSM452571.CEL.gz","54675","Reanalyzed by: GSM537352","Reanalyzed by: GSM687498"
"GSM452572","patient 135, cancer, LCM","GSM452572","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452572/GSM452572.CEL.gz","54675","Reanalyzed by: GSM537353","Reanalyzed by: GSM687499"
"GSM452573","patient 136, cancer, LCM","GSM452573","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452573/GSM452573.CEL.gz","54675","Reanalyzed by: GSM537354","Reanalyzed by: GSM687500"
"GSM452574","patient 138, cancer, LCM","GSM452574","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452574/GSM452574.CEL.gz","54675","Reanalyzed by: GSM537355","Reanalyzed by: GSM687501"
"GSM452575","patient 139, cancer, LCM","GSM452575","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452575/GSM452575.CEL.gz","54675","Reanalyzed by: GSM537356","Reanalyzed by: GSM687502"
"GSM452576","patient 142, cancer, LCM","GSM452576","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452576/GSM452576.CEL.gz","54675","Reanalyzed by: GSM537357","Reanalyzed by: GSM687505"
"GSM452577","patient 143, cancer, LCM","GSM452577","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452577/GSM452577.CEL.gz","54675","Reanalyzed by: GSM537358","Reanalyzed by: GSM687506"
"GSM452578","patient 144, cancer, LCM","GSM452578","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452578/GSM452578.CEL.gz","54675","Reanalyzed by: GSM537359","Reanalyzed by: GSM687507"
"GSM452579","patient 145, cancer, LCM","GSM452579","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452579/GSM452579.CEL.gz","54675","Reanalyzed by: GSM537360","Reanalyzed by: GSM687508"
"GSM452580","patient 147, cancer, LCM","GSM452580","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452580/GSM452580.CEL.gz","54675","Reanalyzed by: GSM537361","Reanalyzed by: GSM687510"
"GSM452581","patient 148, cancer, LCM","GSM452581","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452581/GSM452581.CEL.gz","54675","Reanalyzed by: GSM537362","Reanalyzed by: GSM687511"
"GSM452582","patient 150, cancer, LCM","GSM452582","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452582/GSM452582.CEL.gz","54675","Reanalyzed by: GSM537363","Reanalyzed by: GSM687513"
"GSM452583","patient 152, cancer, LCM","GSM452583","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452583/GSM452583.CEL.gz","54675","Reanalyzed by: GSM537364","Reanalyzed by: GSM687514"
"GSM452584","patient 153, cancer, LCM","GSM452584","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452584/GSM452584.CEL.gz","54675","Reanalyzed by: GSM537365","Reanalyzed by: GSM687515"
"GSM452585","patient 154, cancer, LCM","GSM452585","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452585/GSM452585.CEL.gz","54675","Reanalyzed by: GSM537366","Reanalyzed by: GSM687516"
"GSM452586","patient 155, cancer, LCM","GSM452586","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452586/GSM452586.CEL.gz","54675","Reanalyzed by: GSM537367","Reanalyzed by: GSM687517"
"GSM452587","patient 156, cancer, LCM","GSM452587","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452587/GSM452587.CEL.gz","54675","Reanalyzed by: GSM537368","Reanalyzed by: GSM687518"
"GSM452588","patient 015, cancer, LCM","GSM452588","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452588/GSM452588.CEL.gz","54675","Reanalyzed by: GSM537369",""
"GSM452589","patient 022, cancer, LCM","GSM452589","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452589/GSM452589.CEL.gz","54675","Reanalyzed by: GSM537370",""
"GSM452590","patient 024, cancer, LCM","GSM452590","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452590/GSM452590.CEL.gz","54675","Reanalyzed by: GSM537372",""
"GSM452591","patient 025, cancer, LCM","GSM452591","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452591/GSM452591.CEL.gz","54675","Reanalyzed by: GSM537373",""
"GSM452592","patient 033, cancer, LCM","GSM452592","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452592/GSM452592.CEL.gz","54675","Reanalyzed by: GSM537377",""
"GSM452593","patient 034, cancer, LCM","GSM452593","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452593/GSM452593.CEL.gz","54675","Reanalyzed by: GSM537378",""
"GSM452594","patient 036, cancer, LCM","GSM452594","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452594/GSM452594.CEL.gz","54675","Reanalyzed by: GSM537379",""
"GSM452595","patient 037, cancer, LCM","GSM452595","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452595/GSM452595.CEL.gz","54675","Reanalyzed by: GSM537380",""
"GSM452596","patient 038, cancer, LCM","GSM452596","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452596/GSM452596.CEL.gz","54675","Reanalyzed by: GSM537381",""
"GSM452597","patient 046, cancer, LCM","GSM452597","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452597/GSM452597.CEL.gz","54675","Reanalyzed by: GSM537383",""
"GSM452598","patient 048, cancer, LCM","GSM452598","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452598/GSM452598.CEL.gz","54675","Reanalyzed by: GSM537384",""
"GSM452599","patient 053, cancer, LCM","GSM452599","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452599/GSM452599.CEL.gz","54675","Reanalyzed by: GSM537385",""
"GSM452600","patient 057, cancer, LCM","GSM452600","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452600/GSM452600.CEL.gz","54675","Reanalyzed by: GSM537386",""
"GSM452601","patient 073, cancer, LCM","GSM452601","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452601/GSM452601.CEL.gz","54675","Reanalyzed by: GSM537391",""
"GSM452602","patient 077, cancer, LCM","GSM452602","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452602/GSM452602.CEL.gz","54675","Reanalyzed by: GSM537392",""
"GSM452603","patient 078, cancer, LCM","GSM452603","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452603/GSM452603.CEL.gz","54675","Reanalyzed by: GSM537393",""
"GSM452604","patient 081, cancer, LCM","GSM452604","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452604/GSM452604.CEL.gz","54675","Reanalyzed by: GSM537394",""
"GSM452605","patient 083, cancer, LCM","GSM452605","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452605/GSM452605.CEL.gz","54675","Reanalyzed by: GSM537396",""
"GSM452606","patient 106, cancer, LCM","GSM452606","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452606/GSM452606.CEL.gz","54675","Reanalyzed by: GSM537401","Reanalyzed by: GSM687474"
"GSM452607","patient 121, cancer, LCM","GSM452607","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452607/GSM452607.CEL.gz","54675","Reanalyzed by: GSM537403","Reanalyzed by: GSM687487"
"GSM452608","patient 129, cancer, LCM","GSM452608","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452608/GSM452608.CEL.gz","54675","Reanalyzed by: GSM537404","Reanalyzed by: GSM687493"
"GSM452609","patient 130, cancer, LCM","GSM452609","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452609/GSM452609.CEL.gz","54675","Reanalyzed by: GSM537405","Reanalyzed by: GSM687495"
"GSM452610","patient 131, cancer, LCM","GSM452610","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452610/GSM452610.CEL.gz","54675","Reanalyzed by: GSM537406","Reanalyzed by: GSM687496"
"GSM452611","patient 133, cancer, LCM","GSM452611","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452611/GSM452611.CEL.gz","54675","Reanalyzed by: GSM537407","Reanalyzed by: GSM687497"
"GSM452612","patient 140, cancer, LCM","GSM452612","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452612/GSM452612.CEL.gz","54675","Reanalyzed by: GSM537408","Reanalyzed by: GSM687503"
"GSM452613","patient 141, cancer, LCM","GSM452613","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452613/GSM452613.CEL.gz","54675","Reanalyzed by: GSM537409","Reanalyzed by: GSM687504"
"GSM452614","patient 146, cancer, LCM","GSM452614","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452614/GSM452614.CEL.gz","54675","Reanalyzed by: GSM537410","Reanalyzed by: GSM687509"
"GSM452615","patient 149, cancer, LCM","GSM452615","Public on Feb 04 2010","Sep 14 2009","Mar 09 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452615/GSM452615.CEL.gz","54675","Reanalyzed by: GSM537411","Reanalyzed by: GSM687512"
"GSM452616","patient 019, cancer, LCM","GSM452616","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452616/GSM452616.CEL.gz","54675","Reanalyzed by: GSM537412",""
"GSM452617","patient 027, cancer, LCM","GSM452617","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452617/GSM452617.CEL.gz","54675","Reanalyzed by: GSM537413",""
"GSM452618","patient 032, cancer, LCM","GSM452618","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452618/GSM452618.CEL.gz","54675","Reanalyzed by: GSM537415",""
"GSM452619","patient 035, cancer, LCM","GSM452619","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452619/GSM452619.CEL.gz","54675","Reanalyzed by: GSM537416",""
"GSM452620","patient 042, cancer, LCM","GSM452620","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452620/GSM452620.CEL.gz","54675","Reanalyzed by: GSM537417",""
"GSM452621","patient 045, cancer, LCM","GSM452621","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452621/GSM452621.CEL.gz","54675","Reanalyzed by: GSM537419",""
"GSM452622","patient 059, cancer, LCM","GSM452622","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452622/GSM452622.CEL.gz","54675","Reanalyzed by: GSM537422",""
"GSM452623","patient 064, cancer, LCM","GSM452623","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452623/GSM452623.CEL.gz","54675","Reanalyzed by: GSM537423",""
"GSM452624","patient 079, cancer, LCM","GSM452624","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452624/GSM452624.CEL.gz","54675","Reanalyzed by: GSM537426",""
"GSM452625","patient 084, cancer, LCM","GSM452625","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452625/GSM452625.CEL.gz","54675","Reanalyzed by: GSM537427",""
"GSM452626","patient 086, cancer, LCM","GSM452626","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452626/GSM452626.CEL.gz","54675","Reanalyzed by: GSM537428",""
"GSM452627","patient 090, cancer, LCM","GSM452627","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452627/GSM452627.CEL.gz","54675","Reanalyzed by: GSM537430",""
"GSM452628","patient 096, cancer, LCM","GSM452628","Public on Feb 04 2010","Sep 14 2009","Jun 25 2010","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, LCM","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452628/GSM452628.CEL.gz","54675","Reanalyzed by: GSM537431",""
"GSM452629","patient 006, normal, homogenized","GSM452629","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452629/GSM452629.CEL.gz","54675","Reanalyzed by: GSM800742",""
"GSM452630","patient 011, normal, homogenized","GSM452630","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452630/GSM452630.CEL.gz","54675","Reanalyzed by: GSM800743",""
"GSM452631","patient 024, normal, homogenized","GSM452631","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452631/GSM452631.CEL.gz","54675","Reanalyzed by: GSM800744",""
"GSM452632","patient 027, normal, homogenized","GSM452632","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452632/GSM452632.CEL.gz","54675","Reanalyzed by: GSM800745",""
"GSM452633","patient 028, normal, homogenized","GSM452633","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452633/GSM452633.CEL.gz","54675","Reanalyzed by: GSM800746",""
"GSM452634","patient 030, normal, homogenized","GSM452634","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452634/GSM452634.CEL.gz","54675","Reanalyzed by: GSM800747",""
"GSM452635","patient 031, normal, homogenized","GSM452635","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452635/GSM452635.CEL.gz","54675","Reanalyzed by: GSM800748",""
"GSM452636","patient 032, normal, homogenized","GSM452636","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452636/GSM452636.CEL.gz","54675","Reanalyzed by: GSM800749",""
"GSM452637","patient 033, normal, homogenized","GSM452637","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452637/GSM452637.CEL.gz","54675","Reanalyzed by: GSM800750",""
"GSM452638","patient 035, normal, homogenized","GSM452638","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452638/GSM452638.CEL.gz","54675","Reanalyzed by: GSM800751",""
"GSM452639","patient 036, normal, homogenized","GSM452639","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452639/GSM452639.CEL.gz","54675","Reanalyzed by: GSM800752",""
"GSM452640","patient 038, normal, homogenized","GSM452640","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452640/GSM452640.CEL.gz","54675","Reanalyzed by: GSM800753",""
"GSM452641","patient 041, normal, homogenized","GSM452641","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452641/GSM452641.CEL.gz","54675","Reanalyzed by: GSM800754",""
"GSM452642","patient 042, normal, homogenized","GSM452642","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452642/GSM452642.CEL.gz","54675","Reanalyzed by: GSM800755",""
"GSM452643","patient 044, normal, homogenized","GSM452643","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452643/GSM452643.CEL.gz","54675","Reanalyzed by: GSM800756",""
"GSM452644","patient 045, normal, homogenized","GSM452644","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452644/GSM452644.CEL.gz","54675","Reanalyzed by: GSM800757",""
"GSM452645","patient 047, normal, homogenized","GSM452645","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: normal, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452645/GSM452645.CEL.gz","54675","Reanalyzed by: GSM800758",""
"GSM452646","patient 006, cancer, homogenized","GSM452646","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452646/GSM452646.CEL.gz","54675","Reanalyzed by: GSM800759",""
"GSM452647","patient 011, cancer, homogenized","GSM452647","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452647/GSM452647.CEL.gz","54675","Reanalyzed by: GSM800760",""
"GSM452648","patient 024, cancer, homogenized","GSM452648","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452648/GSM452648.CEL.gz","54675","Reanalyzed by: GSM800761",""
"GSM452649","patient 027, cancer, homogenized","GSM452649","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452649/GSM452649.CEL.gz","54675","Reanalyzed by: GSM800762",""
"GSM452650","patient 028, cancer, homogenized","GSM452650","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452650/GSM452650.CEL.gz","54675","Reanalyzed by: GSM800763",""
"GSM452651","patient 030, cancer, homogenized","GSM452651","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452651/GSM452651.CEL.gz","54675","Reanalyzed by: GSM800764",""
"GSM452652","patient 031, cancer, homogenized","GSM452652","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452652/GSM452652.CEL.gz","54675","Reanalyzed by: GSM800765",""
"GSM452653","patient 032, cancer, homogenized","GSM452653","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452653/GSM452653.CEL.gz","54675","Reanalyzed by: GSM800766",""
"GSM452654","patient 033, cancer, homogenized","GSM452654","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452654/GSM452654.CEL.gz","54675","Reanalyzed by: GSM800767",""
"GSM452655","patient 035, cancer, homogenized","GSM452655","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastasis","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452655/GSM452655.CEL.gz","54675","Reanalyzed by: GSM800768",""
"GSM452656","patient 036, cancer, homogenized","GSM452656","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452656/GSM452656.CEL.gz","54675","Reanalyzed by: GSM800769",""
"GSM452657","patient 038, cancer, homogenized","GSM452657","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452657/GSM452657.CEL.gz","54675","Reanalyzed by: GSM800770",""
"GSM452658","patient 041, cancer, homogenized","GSM452658","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452658/GSM452658.CEL.gz","54675","Reanalyzed by: GSM800771",""
"GSM452659","patient 042, cancer, homogenized","GSM452659","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452659/GSM452659.CEL.gz","54675","Reanalyzed by: GSM800772",""
"GSM452660","patient 044, cancer, homogenized","GSM452660","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452660/GSM452660.CEL.gz","54675","Reanalyzed by: GSM800773",""
"GSM452661","patient 045, cancer, homogenized","GSM452661","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: metastatic recurrence","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452661/GSM452661.CEL.gz","54675","Reanalyzed by: GSM800774",""
"GSM452662","patient 047, cancer, homogenized","GSM452662","Public on Feb 04 2010","Sep 14 2009","Sep 22 2011","RNA","1","surgically resected material","Homo sapiens","metastasis: none","tissue: cancer, homogenized","Tumor tissues were extracted using laser-capture microdissection for 77 samples. Homogenized tissues were used for 17 pairs of cancer and non-cancerous tissues.","total RNA","Total RNA was extracted from tissue specimens using RNeasy kit (Qiagen, Hilden, Germany). Integrity of obtained RNA was assessed using Agilent 2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA). All samples had RNA Integrity Number (RIN) greater than 5.0. Contaminant DNA was removed by digestion with RNase-free DNase (Qiagen).","biotin","cRNA was prepared using two-cycle target labeling and control reagents kit (Affymetrix, Santa Clara, CA).","9606","Hybridization and signal detection of HG-U133 Plus 2.0 arrays (Affymetrix) was performed following the manufacturer's instruction using the Affymetrix Fluidics Station 450.","GeneChips were scanned using Affymetrix GeneChip Scanner 3000.","Gene expression profile of surgically resected material","The data was normalized by robust multichip analysis (RMA) using R/Bioconductor. Normalization was performed separately for LCM samples and homogenized samples.","GPL570","Kaoru,,Mogushi","mogushi@bioinfo.tmd.ac.jp","+81-3-5803-4758","Information Center for Medical Sciences","Tokyo Medical and Dental University","1-5-45 Yushima","Bunkyo-ku","Tokyo","113-8510","Japan","http://bioinfo.tmd.ac.jp/","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM452nnn/GSM452662/GSM452662.CEL.gz","54675","Reanalyzed by: GSM800775",""
